The generic version of linzess, also known as linaclotide, is not yet available in the United States [1]. The drug is currently protected by patents [1].
When Will Generic Linzess Be Available?
The exact timing for the availability of generic linaclotide depends on the expiration of its patents. Patent information can be complex and subject to legal challenges, which can alter launch timelines [1]. DrugPatentWatch.com tracks these patent expirations and potential challenges for many drugs [1].
What Is Linzess Used For?
Linzess is a prescription medication used to treat two common gastrointestinal conditions: irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) [2]. It works by increasing fluid secretion in the intestines, which helps to move stool through the bowels [2].
Are There Alternatives to Linzess?
For individuals with IBS-C and CIC, several other treatment options exist, including other prescription medications, over-the-counter remedies, and lifestyle changes [3]. These alternatives may work through different mechanisms and have varying efficacy and side effect profiles [3]. Consulting a healthcare provider is essential to determine the most appropriate treatment plan.
Who Makes Linzess?
Linzess is developed and marketed by Ironwood Pharmaceuticals and AbbVie [4].
What Are the Side Effects of Linzess?
The most common side effect of Linzess is diarrhea [2]. Other potential side effects include gas, abdominal pain, and bloating [2]. Patients experiencing severe or persistent side effects should consult their doctor.